Inventor · disambiguated record
Jonathan Wong
Also filed as: WONG JONATHAN · WONG JONATHAN P · WONG JONATHAN P H
20 granted patents·9 pending applications·149 citations·filing 1996–2023
94Inventor score
Files withBIOVEC LLC9SEHGAL LAKSHMAN R5ADICET THERAPEUTICS INC2CA MINISTER NAT DEFENCE2CANADA MINISTER DEFENCE2
Top patents by PatentIndex Score
29 records- 0194US7481998B2Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseasesBIOVEC LLC·Filed 2007·Granted Jan 27, 2009·14 cites·9 claims
- 0293US7501114B2Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseasesBIOVEC LLC·Filed 2007·Granted Mar 10, 2009·22 cites·20 claims
- 0392US6468558B2Liposome-encapsulated poly ICLCCA MINISTER NAT DEFENCE·Filed 2001·Granted Oct 22, 2002·37 cites·18 claims
- 0490US7179459B2Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseasesBIOVEC LLC·Filed 2003·Granted Feb 20, 2007·21 cites·14 claims
- 0589US7687058B2Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseasesBIOVEC LLC·Filed 2008·Granted Mar 30, 2010·7 cites·18 claims
- 0688US7670597B2Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseasesBIOVEC LLC·Filed 2006·Granted Mar 2, 2010·7 cites·12 claims
- 0784US7803365B2Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseasesBIOVEC LLC·Filed 2007·Granted Sep 28, 2010·4 cites·14 claims
- 0878US8569255B2Post-exposure therapy of influenza A infectionsWONG JONATHAN P·Filed 2012·Granted Oct 29, 2013·3 cites·13 claims
- 0978US6544958B2Therapy of respiratory influenza virus infection using free and liposome-encapsulated ribonucleotidesCA MINISTER NAT DEFENCE·Filed 2001·Granted Apr 8, 2003·11 cites·12 claims
- 1075US2025332380A1High performance braid-free microcatheters with improved vasculature and lesion crossability characteristics and responseCARDIVASCULAR SYSTEMS·Filed 2023·Application pending·0 cites
- 1175US2025325781A1High performance braid-free microcatheters with improved vasculature and lesion crossability characteristics and responseCARDIVASCULAR SYSTEMS·Filed 2023·Application pending·0 cites
- 1274US8236300B2In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectorsSEHGAL LAKSHMAN R·Filed 2011·Granted Aug 7, 2012·1 cites·11 claims
- 1369US9388427B2In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectorsSEHGAL LAKSHMAN R·Filed 2009·Granted Jul 12, 2016·0 cites·7 claims
- 1467US7713522B2Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseasesBIOVEC LLC·Filed 2008·Granted May 11, 2010·0 cites·11 claims
- 1563US2025345429A1Compositions and methods comprising chimeric adaptor polypeptidesADICET THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1661US2024415953A1Oral therapeutic vaccine compositions, methods and treatment of covidIMMUNITOR THAILAND CO LTD·Filed 2022·Application pending·0 cites
- 1760US9353383B2Vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectorsSEHGAL LAKSHMAN R·Filed 2011·Granted May 31, 2016·0 cites·6 claims
- 1860US2025108069A1Chimeric adaptor polypeptidesADICET THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1959US8367056B2In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectorsBIOVEC LLC·Filed 2011·Granted Feb 5, 2013·0 cites·8 claims
- 2058US8420075B2Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseasesSEHGAL LAKSHMAN R·Filed 2010·Granted Apr 16, 2013·0 cites·18 claims
- 2158US8048410B2In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectorsBIOVEC LLC·Filed 2010·Granted Nov 1, 2011·0 cites·4 claims
- 2257US8242095B2In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectorsSEHGAL LAKSHMAN R·Filed 2010·Granted Aug 14, 2012·0 cites·8 claims
- 2351US2009214638A1Liposome encapsulated poly-iclc method to prophylactically treat an avian influenza viral infectionWONG JONATHAN·Filed 2009·Application pending·0 cites
- 2449US2005106124A1Therapeutic applications of thrombomodulin gene via viral and non-viral vectorsFiled 2004·Application pending·0 cites
- 2546US2003008000A1DNA vaccine using liposome-encapsulated plasmid DNA encoding for hemagglutinin protein of influenza virusFiled 2002·Application pending·0 cites
- 2640US5968548AUse of liposome encapsulated cirprofloxacin as an immunotherapeutic drugCANADA MINISTER DEFENCE·Filed 1997·Granted Oct 19, 1999·9 cites·2 claims
- 2740US5951987APolysaccharide vaccine to enhance immunity against brucellosisCANADA MINISTER DEFENCE·Filed 1996·Granted Sep 14, 1999·8 cites·13 claims
- 2831US6221386B1Use of virulence factors of pathogens to improve liposomal delivery of therapeutic agentsUNITED KINGDOM GOVERNMENT·Filed 1999·Granted Apr 24, 2001·5 cites·12 claims
- 2930US2001007667A1Liposome-encapsulated poly iclcFiled 1999·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →